Vaccination with Replication Deficient Adenovectors Encoding YF-17D Antigens Induces Long-Lasting Protection from Severe Yellow Fever Virus Infection in Mice
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Vaccination with Replication Deficient Adenovectors Encoding YF-17D Antigens Induces Long-Lasting Protection from Severe Yellow Fever Virus Infection in Mice. / Bassi, Maria R; Larsen, Mads Andreas Bay; Kongsgaard, Michael; Rasmussen, Michael; Buus, Søren; Buus, Anette Stryhn; Thomsen, Allan R; Christensen, Jan P.
I: PLoS Neglected Tropical Diseases , Bind 10, Nr. 2, e0004464, 02.2016.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Vaccination with Replication Deficient Adenovectors Encoding YF-17D Antigens Induces Long-Lasting Protection from Severe Yellow Fever Virus Infection in Mice
AU - Bassi, Maria R
AU - Larsen, Mads Andreas Bay
AU - Kongsgaard, Michael
AU - Rasmussen, Michael
AU - Buus, Søren
AU - Buus, Anette Stryhn
AU - Thomsen, Allan R
AU - Christensen, Jan P
PY - 2016/2
Y1 - 2016/2
N2 - The live attenuated yellow fever vaccine (YF-17D) has been successfully used for more than 70 years. It is generally considered a safe vaccine, however, recent reports of serious adverse events following vaccination have raised concerns and led to suggestions that even safer YF vaccines should be developed. Replication deficient adenoviruses (Ad) have been widely evaluated as recombinant vectors, particularly in the context of prophylactic vaccination against viral infections in which induction of CD8+ T-cell mediated immunity is crucial, but potent antibody responses may also be elicited using these vectors. In this study, we present two adenobased vectors targeting non-structural and structural YF antigens and characterize their immunological properties. We report that a single immunization with an Ad-vector encoding the non-structural protein 3 from YF-17D could elicit a strong CD8+ T-cell response, which afforded a high degree of protection from subsequent intracranial challenge of vaccinated mice. However, full protection was only observed using a vector encoding the structural proteins from YF-17D. This vector elicited virus-specific CD8+ T cells as well as neutralizing antibodies, and both components were shown to be important for protection thus mimicking the situation recently uncovered in YF-17D vaccinated mice. Considering that Ad-vectors are very safe, easy to produce and highly immunogenic in humans, our data indicate that a replication deficient adenovector-based YF vaccine may represent a safe and efficient alternative to the classical live attenuated YF vaccine and should be further tested.
AB - The live attenuated yellow fever vaccine (YF-17D) has been successfully used for more than 70 years. It is generally considered a safe vaccine, however, recent reports of serious adverse events following vaccination have raised concerns and led to suggestions that even safer YF vaccines should be developed. Replication deficient adenoviruses (Ad) have been widely evaluated as recombinant vectors, particularly in the context of prophylactic vaccination against viral infections in which induction of CD8+ T-cell mediated immunity is crucial, but potent antibody responses may also be elicited using these vectors. In this study, we present two adenobased vectors targeting non-structural and structural YF antigens and characterize their immunological properties. We report that a single immunization with an Ad-vector encoding the non-structural protein 3 from YF-17D could elicit a strong CD8+ T-cell response, which afforded a high degree of protection from subsequent intracranial challenge of vaccinated mice. However, full protection was only observed using a vector encoding the structural proteins from YF-17D. This vector elicited virus-specific CD8+ T cells as well as neutralizing antibodies, and both components were shown to be important for protection thus mimicking the situation recently uncovered in YF-17D vaccinated mice. Considering that Ad-vectors are very safe, easy to produce and highly immunogenic in humans, our data indicate that a replication deficient adenovector-based YF vaccine may represent a safe and efficient alternative to the classical live attenuated YF vaccine and should be further tested.
KW - Adenoviridae
KW - Animals
KW - Antibodies, Viral
KW - Antigens, Viral
KW - CD8-Positive T-Lymphocytes
KW - Female
KW - Genetic Vectors
KW - Humans
KW - Mice
KW - Mice, Inbred C57BL
KW - Vaccination
KW - Viral Proteins
KW - Yellow Fever
KW - Yellow Fever Vaccine
KW - Yellow fever virus
KW - Research Support, Non-U.S. Gov't
U2 - 10.1371/journal.pntd.0004464
DO - 10.1371/journal.pntd.0004464
M3 - Journal article
C2 - 26886513
VL - 10
JO - P L o S Neglected Tropical Diseases (Online)
JF - P L o S Neglected Tropical Diseases (Online)
SN - 1935-2735
IS - 2
M1 - e0004464
ER -
ID: 163724607